Overview
Mary Buss is a Palliative Medicine specialist and an Oncologist in Farmington, Connecticut. Dr. Buss is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor. Dr. Buss is currently accepting new patients.
Her clinical research consists of co-authoring 57 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
263 Farmington Ave, Farmington, CT 06030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale University
Michael Hurwitz is an Oncologist in New Haven, Connecticut. Dr. Hurwitz is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Adult Soft Tissue Sarcoma, and Orchiectomy.
Yale University
Mario Sznol is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Sznol has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes.
Yale University
Harriet Kluger is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Kluger is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Endometrial CancerDr. Buss isAdvanced. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian Tumor
- Ovarian CancerDr. Buss isAdvanced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Buss isAdvanced. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Buss isAdvanced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Buss isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Buss isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Buss isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Buss isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Buss isExperienced. Learn about Lung Cancer.
- MelanomaDr. Buss isExperienced. Learn about Melanoma.